One Biosciences Announces Data Validating New Method for Single-Cell Transcriptomic Tumor Profiling from Clinical Pathology Samples

Contributed by: Business Wire

Logo

Tags

Technology

Medical Devices

Other Technology

Software

Other Health

Biotechnology

Pharmaceutical

Health

Oncology

Artificial Intelligence

Single-Cell Transcriptomic Tumor Profiling

More Like This

Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology

Parse Biosciences Announces FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis

One Biosciences Receives BOOST Funding From Paris-Saclay Cancer Cluster to Advance the First Single-Cell Assay Approach for ADC Therapies

Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research

PR Newswire associated0

Lexogen launches end-to-end solutions for FFPE Transcriptomics

Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis

Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing

Parse Biosciences Launches the Next Generation of its Immune Profiling Kits